Sphingomonas paucimobilis bacteremia and tricuspid valve endocarditis in a patient with intravenous drug use

Nandy, 2013, Community acquired bacteremia by sphingomonas paucimobilis: two rare case reports, J Clin Diagn Res, 7, 2947 Cheong, 2008, Clinical features and treatment outcomes of infections caused by Sphingomonas paucimobilis, Infect Control Hosp Epidemiol, 29, 990, 10.1086/591091 Koskinen, 2000, Characterization of Sphingomonas isolates from Finnish and Swedish drinking water distribution systems, J Appl Microbiol, 89, 687, 10.1046/j.1365-2672.2000.01167.x Yabuuchi, 1990, Proposals of Sphingomonas paucimobilis gen. nov. and comb. nov., Sphingomonas parapaucimobilis sp. nov., Sphingomonas yanoikuyae sp. nov., Sphingomonas adhaesiva sp. nov., Sphingomonas capsulata comb. nov., and two genospecies of the genus Sphingomonas, Microbiol Immunol, 34, 99, 10.1111/j.1348-0421.1990.tb00996.x Lin, 2010, Sphingomonas paucimobilis bacteremia in humans: 16 case reports and a literature review, J Microbiol Immunol Infect, 43, 35, 10.1016/S1684-1182(10)60005-9 Rognrud, 2020, Bacterial endocarditis caused by sphingomonas paucimobilis: a case report and literature review, Case Rep Infect Dis, 2020, 7185834 Kuo, 2009, Sphingomonas paucimobilis bacteraemia and septic arthritis in a diabetic patient presenting with septic pulmonary emboli, J Med Microbiol, 58, 1259, 10.1099/jmm.0.009985-0 Toh, 2011, Risk factors associated with Sphingomonas paucimobilis infection, J Microbiol Immunol Infect, 44, 289, 10.1016/j.jmii.2010.08.007